AHArtur Haddad Herdy

Artur Haddad Herdy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Artur Haddad Herdy has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Systematic Review on the Safety of Physical Exercise in Hypertrophic Cardiomyopathy: Recommendations from the Brazilian Society of Cardiology

    by Ricardo Stein, Rodrigo Otávio Bougleux Alô, Luiz Eduardo Fonteles Ritt, Alexsandro Alves Fagundes, Anderson Donelli da Silveira, Artur Haddad Herdy, Clea Colombo, Cristiano Faria Pisani, Fabrício Braga, Frank Nunes, et al.

    Background Although historically discouraged due to the risk of arrhythmias and sudden cardiac death (SCD), physical exercise (PE) may be safe and beneficial for individuals with hypertrophic cardiomyopathy (HCM). Objective To evaluate the association between PE and the incidence of mortality and arrhythmic events in adults with HCM, stratifying the analysis according to different types and intensities of exercise. Methods Systematic review of randomized clinical trials (RCTs) and observational studies identified in PubMed, Embase, and the Cochrane Library through December 2024. Studies including individuals exposed to different intensities of PE were eligible. Risk of bias was assessed using the RoB 2 and ROBINS-I tools, and certainty of evidence using GRADE. Recommendations were developed by an expert panel of the Brazilian Society of Cardiology. Results Eight studies (four RCTs and four observational studies; 9,744 participants) were included. None reported an increased risk of mortality or severe arrhythmic events associated with PE, even at moderate or vigorous intensities. Syncope was rare. Additionally, a Korean observational study involving more than 7,000 participants (mean age: 59 years) demonstrated reduced all-cause mortality with higher physical activity intensity (dose–response curve). In low-risk athletes, competitive sports were not associated with severe adverse events. The quality of evidence ranged from moderate to very low. Conclusion PE in HCM should be encouraged based on individualized assessment. In patients without high-risk criteria for SCD, benefits appear to outweigh risks. For higher-risk subgroups, recommendations are more cautious and based on expert consensus.

  • Open Access

    Revisão Sistemática sobre a Segurança do Exercício Físico na Cardiomiopatia Hipertrófica: Recomendações da Sociedade Brasileira de Cardiologia

    by Ricardo Stein, Rodrigo Otávio Bougleux Alô, Luiz Eduardo Fonteles Ritt, Alexsandro Alves Fagundes, Anderson Donelli da Silveira, Artur Haddad Herdy, Clea Colombo, Cristiano Faria Pisani, Fabrício Braga, Frank Nunes, et al.

    Resumo Fundamento Embora historicamente desaconselhado devido ao risco de arritmias e morte súbita cardíaca (MSC), o exercício físico (EF) pode ser seguro e benéfico para indivíduos com cardiomiopatia hipertrófica (CMH). Objetivo Avaliar a associação entre a prática de EF e a incidência de mortalidade e de eventos arrítmicos em adultos portadores de CMH, estratificando a análise conforme os diferentes tipos e intensidades de exercício realizados. Métodos Revisão sistemática de ensaios clínicos randomizados (ECRs) e estudos observacionais identificados nas bases de dados PubMed, Embase e Cochrane Library até dezembro de 2024. Foram incluídos estudos com indivíduos submetidos a diferentes intensidades de EF. O risco de viés foi avaliado pelas ferramentas RoB 2 e ROBINS-I, e a certeza da evidência, pela ferramenta GRADE. As recomendações foram elaboradas por um painel de especialistas da Sociedade Brasileira de Cardiologia. Resultados Oito estudos (quatro ECRs e quatro observacionais; 9744 participantes) foram incluídos. Nenhum deles relatou aumento no risco de mortalidade ou de eventos arrítmicos graves associados ao EF, mesmo em intensidades moderadas ou vigorosas. A ocorrência de síncope foi rara. Além disso, um estudo observacional coreano, envolvendo mais de 7 mil participantes (idade média: 59 anos), demonstrou redução da mortalidade por todas as causas com maior intensidade de atividade física (curva dose-resposta). Em atletas de baixo risco, o esporte competitivo não se associou a eventos adversos graves. A qualidade da evidência variou de moderada a muito baixa. Conclusão O EF na CMH deve ser incentivado com base em avaliação individualizada. Em pacientes sem critérios para alto risco de MSC, os benefícios parecem superar os riscos. Para subgrupos de maior risco, a recomendação é mais cautelosa e baseada em consenso de especialistas.

  • Open Access

    Position Statement on Cardiovascular Emergencies at Sporting Events – 2026

    by Luiz Eduardo Fonteles Ritt, Antonio Carlos Avanza Junior, Ricardo Stein, Rodrigo Otavio Bougleux Alô, Marcelo Bichels Leitão, Arthur Haddad Herdy, Marconi Gomes, Carolina Christianini Mizzaci, Anderson Donelli da Silveira, Fabio de Freitas Guimarães Guerra, et al.

  • Open Access

    Posicionamento sobre Emergências Cardiovasculares para Eventos Esportivos – 2026

    by Luiz Eduardo Fonteles Ritt, Antonio Carlos Avanza Junior, Ricardo Stein, Rodrigo Otavio Bougleux Alô, Marcelo Bichels Leitão, Arthur Haddad Herdy, Marconi Gomes, Carolina Christianini Mizzaci, Anderson Donelli da Silveira, Fabio de Freitas Guimarães Guerra, et al.

    Sumário […] Posicionamento sobre Emergências Cardiovasculares para Eventos Esportivos – 2026 Sumário […] Posicionamento sobre Emergências Cardiovasculares para Eventos Esportivos – 2026

  • Distinct early repolarisation patterns in male Brazilian soccer players: insights from a multicentre study

    by Filipe Ferrari, Anderson D da Silveira, Arthur P Rossi, Luana G Pedrotti, Guilherme D Dilda, Haroldo C Aleixo, Flávia C O Magalhães, Luiz G M Emed, Luciano G Soares, Fernando B Cardoso, et al.

    Background Early repolarisation (ER) is commonly observed during cardiovascular screenings of young athletes and can present with various morphologies. However, its prevalence and clinical significance in male Brazilian soccer players have not been characterised. This study aimed to compare the prevalence of different ER patterns and assess their potential clinical significance in this population. Methods In this multicentre observational study, we analysed ECG data from male Brazilian soccer players who underwent preparticipation evaluations at 83 professional clubs across Brazil’s five geographic regions between February 2002 and August 2024. Our analysis included white, mixed-race and black athletes, as well as seven distinct ER morphologies. Poisson regression with robust variance was used to derive age-adjusted prevalence ratios for the different ER morphologies. Results We included 6353 athletes (median (IQR) age: 19 (16–23) years; 2556 white, 2071 mixed-race and 1726 black individuals). ER patterns appeared in 2552 (40.2%) players. The most common ER morphologies with ST-segment elevation (STE) were a classic J-wave with ascending ST-segment (1275; 20.1%) and a discrete J-point with ascending ST-segment (735; 11.6%) in leads V4–V6. Without STE, the most frequent patterns were a slur on the downslope of the R-wave with ascending ST- segment (760; 12%), a slur with horizontal ST-segment (335; 5.3%) and a J-wave (199; 3.1%) in leads II, III and aVF. ER was more prevalent in black (48.1%) than in white (34.4%) or mixed-race (40.6%) athletes. Over a mean follow-up period of 4.4±3.1 years, no cases of sudden cardiac death were identified. Conclusions Our findings do not suggest that ER patterns observed in male Brazilian soccer players are associated with sudden cardiac death. Given the role of Brazil in exporting soccer talent, our results may help guide athlete assessments of ER worldwide.


  • Open Access

    Cardiovascular Telerehabilitation: An Alternative for Greater Availability of Cardiovascular and Metabolic Rehabilitation in Brazil

    by Artur Haddad Herdy, Ariella Sebastião Mangia, Magnus Benetti

    Cardiovascular telerehabilitation – concept CTR is a program that comprises one or more components of traditional CVR, commonly offered in CVR programs at home or outside a hospital/specialized center environment; it is delivered through digital technology (telemonitoring, e-learning, telecoaching). Its objective is to manage CVD and improve different physical, emotional, psychological, and social aspects of patients, especially those located in areas with low levels of access, whether due to their place of residence or difficulty in accessing advanced care., […] [...] Cardiovascular telerehabilitation – concept CTR is a program that comprises one or more components of traditional CVR, commonly offered in CVR programs at home or outside a hospital/specialized center environment; it is delivered through digital technology (telemonitoring, e-learning, telecoaching). Its objective is to manage CVD and improve different physical, emotional, psychological, and social aspects of patients, especially those located in areas with low levels of access, whether due to their place of residence or difficulty in accessing advanced care., […]


  • Open Access

    Telerreabilitação Cardiovascular: Uma Alternativa para Maior Disponibilidade da Reabilitação Cardiovascular e Metabólica no Brasil

    by Artur Haddad Herdy, Ariella Sebastião Mangia, Magnus Benetti

    Telerreabilitação cardiovascular – conceito A TRC é um programa que compreende um ou mais componentes da RCV tradicional, comumente ofertados em programas de RCV domiciliar, ou fora do ambiente hospitalar/centro especializado; é entregue por meio de tecnologia digital (telemonitoramento, e-learning, telecoaching). Tem por objetivo o manejo da DCV e a melhora de diferentes aspectos físicos, emocionais, psicológicos e sociais dos pacientes, em especial aqueles localizados em áreas com baixos níveis de acesso, seja pelo local de moradia ou dificuldade de [...] Telerreabilitação cardiovascular – conceito A TRC é um programa que compreende um ou mais componentes da RCV tradicional, comumente ofertados em programas de RCV domiciliar, ou fora do ambiente hospitalar/centro especializado; é entregue por meio de tecnologia digital (telemonitoramento, e-learning, telecoaching). Tem por objetivo o manejo da DCV e a melhora de diferentes aspectos físicos, emocionais, psicológicos e sociais dos pacientes, em especial aqueles localizados em áreas com baixos níveis de acesso, seja pelo local de moradia ou dificuldade de

  • Open Access

    Efetividade e Segurança da Edoxabana nos Cuidados Clínicos de Rotina de Pacientes com Fibrilação Atrial no Brasil: Estudo Prospectivo de Acompanhamento de 1 Ano – EdoBRA

    by Dalton Bertolim Precoma, Rafael Paletta da Silva, Luiz Carlos Santana Passos, Conrado Roberto Hoffman Filho, Fábio Serra Silveira, José Tarcísio Medeiros de Vasconcelos, Sérgio Luiz Zimmermann, Artur Haddad Herdy, Alessandra Ritter, Daniely Freitas-Alves, et al.

    Resumo Fundamento A edoxabana é um anticoagulante oral que se mostrou segura e eficaz na prevenção de acidente vascular cerebral em pacientes com fibrilação atrial (FA). Dada a ampla utilização da edoxabana desde sua aprovação, é crucial avaliar seu desempenho no contexto clínico brasileiro. Objetivos O objetivo do estudo foi descrever a segurança e a efetividade da edoxabana no tratamento de pacientes com FA no Brasil. Métodos O EdoBRA é um estudo multicêntrico, prospectivo, observacional, conduzido em 30 centros de pesquisa no Brasil. Eventos de sangramento foram considerados medidas de segurança, e eventos cardiovasculares foram considerados para medidas de efetividade. Análises descritivas foram realizadas. Curvas de Kaplan-Meier foram geradas para análise do tempo para o evento, e um intervalo de confiança de 95% usado conforme apropriado. Resultados Entre os 705 pacientes recrutados, 590 foram incluídos na análise por apresentarem pelo menos um evento relatado ou durante o seguimento. As médias (±DP) dos escores de risco CHA2DS2-VASc e HAS-BLED foram, respectivamente, 3 (3,3 ± 1,6) e 2 (1,8 ± 1,2). Durante o acompanhamento de um ano, foram relatados nove sangramentos maiores, incluindo cinco casos de sangramento gastrointestinal [PI 0,85 (IC95% =0,82; 0,88]). Entre os eventos cardiovasculares registrados (n=68), houve quatro eventos de acidente vascular cerebral [PI 0,68 (IC 95% 0,65; 0,71)], um ataque isquêmico transitório [PI 0,17 (IC 95% 0,16; 0,18)] e um tromboembolismo venoso [PI 0,17 (IC 95% 0,16; 0,18)]. Nenhum evento embólico sistêmico foi relatado. Conclusão Em uma população idosa com várias comorbidades, recebendo edoxabana como tratamento de rotina para FA, as taxas de evento cardiovasculares sangramento maior foram baixas.


  • Open Access

    Effectiveness and Safety of Edoxaban in the Routine Clinical Care of Atrial Fibrillation Patients in Brazil: Prospective 1-Year Follow-Up Study – EdoBRA

    by Dalton Bertolim Precoma, Rafael Paletta da Silva, Luiz Carlos Santana Passos, Conrado Roberto Hoffman Filho, Fábio Serra Silveira, José Tarcísio Medeiros de Vasconcelos, Sérgio Luiz Zimmermann, Artur Haddad Herdy, Alessandra Ritter, Daniely Freitas-Alves, et al.

    Background Edoxaban, an orally administered anticoagulant, has been shown to be safe and effective in preventing stroke in atrial fibrillation (AF) patients. Given its widespread use since approval, evaluating edoxaban’s real-world performance in the Brazilian clinical context is crucial. Objective The study aimed to report the one-year safety and effectiveness of edoxaban in AF patients in Brazil. Methods EdoBRA is a multi-center, prospective, observational investigation conducted across 30 Brazilian research sites. Bleeding events were considered as safety measures and cardiovascular events were considered for effectiveness measures. Descriptive analyses were performed. Kaplan-Meier curves were generated for time-to-event analysis and a 95% confidence interval was used as appropriate. Results Among the 705 enrolled participants, 590 were included in the analysis for having at least one follow-up or one reported event. Mean (±SD) CHA2DS2-VASc risk score was 3 (3.3 ± 1.6) and the mean HAS-BLED risk score was 2 (1.8 ± 1.2). During the one-year follow-up period, nine major bleedings events were reported, including five cases of gastrointestinal bleeding (IP 0.85 [95% CI =0.82; 0.88]). Among the cardiovascular events recorded (N = 68), there were four stroke events (IP 0.68 [CI 95% 0.65;0.71]), one transient ischemic attack (IP 0.17 [CI 95% (0.16;0.18]) and 1 event was Venous Thromboembolic Events (IP 0.17 [CI 95% (0.16;0.18]). No systemic embolic event was exhibited by any patient. Conclusion In an elderly population with several comorbidities routinely treated with edoxaban for AF, the rates of cardiovascular event and major bleeding were low.


  • Imaging associations enhance the understanding of ECG abnormalities in male Brazilian football players: findings from the B-Pro Foot ECG study

    by Filipe Ferrari, Anderson D da Silveira, Patrícia K Ziegelmann, Haroldo Aleixo, Guilherme D Dilda, Luiz G M Emed, Flávia C O Magalhães, Fernando B Cardoso, Henrique C da Silva, Felipe E F Guerra, et al.

    Objectives To evaluate the prevalence of abnormal ECG findings and their association with imaging results in male Brazilian football players. Methods The ‘B-Pro Foot ECG’ is a multicentre observational study conducted in 82 Brazilian professional clubs. It analysed 6125 players aged 15–35 years (2496 white, 2004 mixed-race and 1625 black individuals) who underwent cardiovascular screening from 2002 to 2023. All ECGs were reviewed by two experienced cardiologists in the athlete’s care. Those with abnormal findings underwent further investigations, including a transthoracic echocardiogram (TTE). Cardiac magnetic resonance (CMR) was subsequently performed based on TTE findings or clinical suspicion. Results In total, 180 (3%) players had abnormal ECGs and 176 (98%) showed normal TTE results. Athletes aged 26–35 years had a higher prevalence of abnormal ECGs than younger athletes (15–25 years). Black players had a higher prevalence of T-wave inversion (TWI) in the inferior leads than white players (2.6% vs 1.4%; p=0.005), as well as in V5 (2.9%) and V6 (2.1%) compared with white (1.2% and 1.0%; pConclusion This study found a 3% prevalence of abnormal ECGs in male Brazilian football players. Inferolateral TWI was associated with cardiac pathologies confirmed by CMR, even in athletes with a normal TTE.